We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Guidance Clarifies eSubmission Format Using eCTD Specs
Guidance Clarifies eSubmission Format Using eCTD Specs
All drug and biologic applications and drug master files must be submitted electronically by May 15, 2017, and all commercial investigational new drug applications one year later, under final guidance from the U.S. Food and Drug Administration.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor